FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

1  Specify and/or confirm previous Hepatitis B surface antigen (HBsAg) testing performed and reported on the Form 2000- Recipient Baseline Data:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  

 

Provide all documented hepatitis B viral load levels obtained within 3 months prior to the preparative regimen. If no values were obtained in the 3 months prior to the preparative 

regimen, provide and date the most recent values obtained prior to the preparative regimen.  
 
2  Date: __ __ __ __ - __ __- __ __  

  
 
3  Hepatitis B viral load level:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 nmlkji
copies/mL  

 nmlkji
pg/mL  

 
 
4  Date: __ __ __ __ - __ __- __ __  

  
 
5  Hepatitis C viral load:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 
 

6  Were any liver biopsies performed for cytology and/or pathology prior to HSCT?

    
 nmlkji

yes   – Attach a copy of liver cytology / pathology report(s). 

 nmlkji
no  

 
 

7  Did the recipient receive therapy for hepatitis prior to HSCT?

    
 nmlkji

yes  
 nmlkji

no  

  Key Fields 

Serological Evidence of Prior Hepatitis Exposure / Infection - Recipient Questions: 1 - 6

  Pre-HSCT recipient Hepatitis B (1) Questions: 2 - 3 

  Pre-HSCT recipient Hepatitis C (1) Questions: 4 - 5 

  History of Antiviral Therapy for Hepatitis - Recipient Questions: 7 - 26

  Lamivudine Therapy (1) Questions: 8 - 13 

Form 2047 R3.0: Hepatitis Serology Pre-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2047 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 3



 

Lamivudine therapy given? 
 

8  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
9  Date Started: __ __ __ __ - __ __- __ __  

 
 
10  Daily Dose:    mg 

 
 
11  Reason Started:   

 
 

12  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
13  Date Stopped: __ __ __ __ - __ __- __ __  

 

Interferon therapy given? 
 

14  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
15  Date Started: __ __ __ __ - __ __- __ __  

 
 
16  Daily Dose:    mg 

 
 
17  Reason Started:   

 
 

18  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
19  Date Stopped: __ __ __ __ - __ __- __ __  

 
 

20  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
21  Specify other antiviral therapy given:    

 
 
22  Date Started: __ __ __ __ - __ __- __ __  

 
 
23  Daily Dose:    mg 

 
 
24  Reason Started:   

 
 

25  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
26  Date Stopped: __ __ __ __ - __ __- __ __  

 
 

27  Hepatitis B core antibody (HBcAb)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 
 

28  Hepatitis B surface antigen (HBsAg)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

 
 

29  Hepatitis B e antigen (HBeAg)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  

 
 

30  Hepatitis C antibody (HCAb)

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

Not tested  
 nmlkji

confirm prior result  

  Interferon Therapy (1) Questions: 14 - 19 

  Other Antiviral Therapy (1) Questions: 20 - 26 

Serological Evidence of Prior Hepatitis Exposure / Infection - Donor Questions: 27 - 34

  Hepatitis B Viral Load Level (1) Questions: 31 - 32 

Form 2047 R3.0: Hepatitis Serology Pre-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2047 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 3



 
 
31  Date: __ __ __ __ - __ __- __ __  

  
 
32  Hepatitis B viral load level:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 nmlkji
copies/mL  

 nmlkji
pg/mL  

 
 
33  Date: __ __ __ __ - __ __- __ __  

  
 
34  Hepatitis C viral load:    

 

 nmlkji
log IU  

 nmlkji
IU/mL  

 
 

35  Did the donor receive therapy for hepatitis prior to the stem cell harvest?

    
 nmlkji

yes  
 nmlkji

no  

 
 

36  Lamivudine therapy given?

    
 nmlkji

yes  
 nmlkji

no  

 
 
37  Date Started: __ __ __ __ - __ __- __ __  

 
 

38  Currently receiving?

    
 nmlkji

yes  
 nmlkji

no  

 
 

39  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
40  Date Stopped: __ __ __ __ - __ __- __ __  

 
 
41  Reason Stopped:   

 
 

42  Intreferon therapy given?

    
 nmlkji

yes  
 nmlkji

no  

 
 
43  Date Started: __ __ __ __ - __ __- __ __  

 
 

44  Currently receiving?

    
 nmlkji

yes  
 nmlkji

no  

 
 

45  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
46  Date Stopped: __ __ __ __ - __ __- __ __  

 
 
47  Reason Stopped:   

 
 

48  Other antiviral therapy given?

    
 nmlkji

yes  
 nmlkji

no  

 
 
49  Specify other therapy:    

 
 
50  Date Started: __ __ __ __ - __ __- __ __  

 
 

51  Currently Receiving?

    
 nmlkji

yes  
 nmlkji

no  

 
 

52  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
53  Date Stopped: __ __ __ __ - __ __- __ __  

 
 
54  Reason Stopped:   

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

  Hepatitis C Viral Load Level (1) Questions: 33 - 34 

  History of Antiviral Therapy for Hepatitis - Donor Questions: 35 - 54

Form 2047 R3.0: Hepatitis Serology Pre-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2047 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 3